PriscillaFurthMD
Infectious Disease • Washington, DCProfessor, Associate Dean, Medical Center; Professor, Lombardi Comprehensive Cancer Center (LCCC), GUMC Faculty Affairs, Georgetown University Hospital
Are you Dr. Furth?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-2798
Summary
- Dr. Priscilla Furth, MD is an infectious disease specialist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia and Maryland. She is affiliated with MedStar Georgetown University Hospital and is a Professor at Medical Center; Professor.
Education & Training
Yale School of MedicineClass of 1979
National Institutes of Health Clinical CenterFellowship, Infectious Disease
Certifications & Licensure
MD State Medical License 1985 - 2026
DC State Medical License 2002 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 52 citationsThe Stat3/5 locus encodes novel endoplasmic reticulum and helicase-like proteins that are preferentially expressed in normal and neoplastic mammary tissue.Yongzhi Cui, Minglin Li, Katherine D. Walton, Kailai Sun, John A. Hanover
Genomics. 2001-12-01 - 18 citationsBNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant.Ludwig Knabl, Hye Kyung Lee, Manuel Wieser, Anna Mur, August Zabernigg
Communications Medicine. 2022-01-01 - 426 citationsCre-mediated gene deletion in the mammary gland.Kay Uwe Wagner, Robert J. Wall, Luc St-Onge, Peter Gruss, Anthony Wynshaw-Boris
Nucleic Acids Research. 1997-11-01
Press Mentions
Breast Cancer’s Prognostic Toolkit Expands for Post-Menopausal WomenDecember 1st, 2022- Study in Mice Suggests That Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention StrategiesDecember 1st, 2022
- Health News | Researchers Discover New Approach to Detect Early Signs of Breast CancerSeptember 14th, 2022
- Join now to see all
Grant Support
- Mechanisms Regulating Reversal Of MalignancyNational Cancer Institute2006–2009
- Progression And Regression Of Mammary PreneoplasiaNational Cancer Institute2005–2009
- Mechanisms Regulating Reversal Of PremalignancyNational Cancer Institute2001–2005
- Mechanisms Regulating Reversal Of PremalignancyNational Cancer Institute2001
- BCL-2 Gene Family, Apoptosis Resistance And Breast CanceNational Cancer Institute1996–2000
- BCL-2 Gene Family, Apoptosis Resistance &Breast CancerNational Cancer Institute1998–1999
- BCL2 Gene Family, Apoptosis Resistance And Breast CanceNational Cancer Institute1998
- Hormonal Effects On Apoptosis In Breast CancerNational Cancer Institute1995–1996
Professional Memberships
- Member
